Solvemed focuses on developing digital biomarkers for neurodegenerative diseases, such as Parkinson's disease, using their proprietary machine learning technology. Their products enable better care and improved treatment outcomes for neurology patients, and they also help biopharmaceutical industry partners drive clinical trial efficiency. Solvemed's work is based on world-class science, and they collaborate with clinical researchers from top research institutions.